Investor FAQs
LIPH AG's business model is built on scalability, innovation, and synergy. The Company's strategy focuses on the acquisition, strategic development, and long-term value enhancement of attractive portfolio companies. LIPH AG aims to create sustainable shareholder value through the continued development of its portfolio, organic revenue growth, and income from licensing and royalty models.
The ticker symbol is LEOW.
The company's dividend policy for the financial year 2025 shall be to retain all earnings within the business to fund strategic growth initiatives. No dividends will be declared or paid to shareholders during this period, as reinvestment of profits is deemed the optimal strategy for enhancing long-term shareholder value and maximizing capital appreciation.
SPOBAG AG used to be a listed shell company. With the completion of the reverse-IPO via a mandatory takeover process completed in June 2025, SPOBAG AG became Leo International Precision Health AG with its new business purpose.
To ensure transparency and comply with applicable capital markets disclosure requirements, historical corporate documents of the former SPOBAG AG remain available in the archive section of the Company's website. These documents relate to the Company's business activities prior to its strategic transformation in 2025.
Email Alerts
To opt-in for investor email alerts, please select at least one alert option and enter your email address in the field below. After submitting your request, an activation email will be sent to the address provided. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. If you would like to opt out of email alerts, you can unsubscribe here.